April 16, 2025
Operating Assets

Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

Dose expansion in Phase 1 CARDINAL trial of TERN-701 for chronic myeloid leukemia (CML) expected to initiate in 2Q25 with additional safety and efficacy data in 4Q25 First patient enrolled in Phase 2 FALCON trial of TERN-601 for obesity with 12-week data expected 4Q25 Cash, cash equivalents and marketable securities of $358 million, expected to

Read More
Financial Assets

How much money Tennessee receives

Is this the end of the Department of Education? Recent moves by the Trump administration effectively signal his fulfillment of a campaign promise to end ED. President Donald Trump is expected to sign an executive order Thursday afternoon aimed at dismantling the U.S. Department of Education. According to the order, the department aims to “return

Read More
Operating Assets

Touax: RESULTS 2024 Growth in turnover and operating profitability

PRESS RELEASE        Paris, 20 March 2025 – 5:45 pm YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION RESULTS 2024 Growth in turnover and operating profitability Turnover1 of €165.0m, up +€7.9m Increase of the operating EBITDA2 to €59.0m (+€3.6m) Group share of net profit: €3.9m (+€0.3m) Book value per share: €11.63 (+6%) Dividend increase to €0.15 per share

Read More
Intangible Assets

Impact Analytics Partners with Lovisa To Deliver AI-Optimized Planning, Forecasting, Inventory Management and More

Australian Jewelry Brand to Leverage AI-Driven Tools to Support its Global Expansion MELBOURNE, Australia and NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) — Impact Analytics™, the leader in end-to-end AI-native planning, merchandising and pricing solutions for the retail, grocery, and CPG industries, today announced that it has partnered with Australian fashion jewelry brand Lovisa to

Read More
Operating Assets

Metagenomi Reports Business Updates and Full Year 2024 Financial Results

Hemophilia A presentation at American Society of Hematology (ASH) 66th Annual Meeting demonstrated sustained Factor VIII (FVIII) activity in nonhuman primate (NHP) study for more than 16 months Leveraged hemophilia A albumin platform to achieve in vivo proof-of-concept in multiple secreted protein deficiencies to support wholly-owned follow-on program Progressed four Wave 1 Ionis targets to

Read More
Fixed Assets

Term Structure Institutional (TSI): The Future of Institutional Fixed-Rate Digital Asset Lending and Borrowing

HONG KONG, March 17, 2025 /PRNewswire/ — Redefining Institutional Finance in the Digital Asset Era As institutional adoption of digital assets accelerates, the demand for reliable, predictable, and efficient lending and borrowing solutions has never been greater. Term Structure Institutional (TSI) is at the forefront of this transformation, offering a cutting-edge fixed-rate borrowing and lending

Read More
Fixed Assets

GROW with Singlife and aberdeen Launch New Exclusive Share Class of Global Income Bond Fund to Deliver Sustainable Payouts Amid Market Volatility

Globally diversified portfolio of crossover bonds aims to deliver attractive yields for investors SINGAPORE – Media OutReach Newswire – 14 March 2025 – GROW with Singlife (“GROW”), the integrated investment platform under leading homegrown financial services company Singlife, in partnership with aberdeen Investments (“aberdeen”), today launches a new share class of the abrdn SICAV II

Read More
Operating Assets

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

–  Company is applying its T cell-selective lipid nanoparticle to develop siRNA therapeutics for T cell-driven autoimmune diseases –  Lead target and indication to be announced MY 2025 –  Cash balance of $185.2 million expected to fund operations into 2H 2027 Get the latest news delivered to your inbox Sign up for The Manila Times

Read More
Operating Assets

Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights

– Sutro announced a strategic portfolio review resulting in prioritization of wholly-owned next-generation ADC programs; Key management changes announced as part of transition – – Cash, cash equivalents and marketable securities as of December 31, 2024 of $316.9 million, with cash runway expected into at least Q4 2026, excluding anticipated milestones from existing collaborations –

Read More
Operating Assets

ContextLogic Inc. Reports Fourth-Quarter and Fiscal Year 2024 Financial Results

OAKLAND, Calif., March 12, 2025 (GLOBE NEWSWIRE) — ContextLogic Inc. (Nasdaq: LOGC) (“ContextLogic,” the “Company,” “we” or “our”) today reported its financial results for the quarter and fiscal year ended December 31, 2024. Company Update During 2024, management took several significant steps in the evolution of the Company’s business. These included, first, the sale of

Read More